Manufacturing Agreements  >  Manufacturing Supply Agreements  >  Biotechnology / Pharmaceuticals  >  Agreement Preview
Agreement#: AG-346814
Pages: 6 pages
Format: MS Word, WordPerfect and other RTF formats are supported. MS Word Compatible
Price: $35.00
Click the "Add To Cart" button to download the full agreeement.
Add To Cart


Stock Option Agreement Between Thomas Drees And LKB Partners, LLC

Effective Date: November 21, 2007
Parties:

Sanguine

Sectors: Biotechnology / Pharmaceuticals
Governing Law:  California
Stock Option Agreement


THIS AGREEMENT made as of this 21st day of November, 2007 by and between Thomas C. Drees, an individual of Pasadena, CA (the " Optionor" ) and LKB Partners, LLC, of Exton, PA (the " Optionee" ).


WHEREAS :


(A) The Optionor is the legal and beneficial owner of 42 million common (est.) shares (the " Optionor' s Shares" ) in the capital stock of Sanguine Corp (SGNC.OB) (the " Corporation" ); and


(B) The Optionor wishes to grant to the Optionee and the Optionee wishes to accept from the Optionor, an option to purchase 10 million of the Optionor' s Shares (the " Optioned Shares" );


NOW THEREFORE THIS AGREEMENT WITNESSES that in consideration of the premises and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Optionor hereby grants to the Optionee an option (the " Option" ) to purchase the Optioned Shares at a purchase price (the " Purchase Price" ) of $0.035 per share for an aggregate Purchase Price of $350,000, upon and subject to the following terms and conditions:


1. Option Exercise Period . The Option may be exercised by the Optionee in whole or in part at any time from the date hereof until the day preceding the earlier of (i) 5 years from the execution date of this Agreement, or (ii) the death of the Optionee (the earliest of which dates shall be the " Termination Date" ...

*End of Preview*
Click the 'Add to Cart' button to download the complete and formatted agreement.